{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T21:36:43Z","timestamp":1768772203675,"version":"3.49.0"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Overactive bladder (OAB) is a significant public health issue that adversely affects the quality of life of patients and imposes a significant socioeconomic burden, with varying prevalence rates across study populations in Chinese women. A systematic review and meta-analysis were conducted to estimate the prevalence of OAB in Chinese women.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Relevant published articles on the prevalence of OAB in Chinese women were searched through July 21, 2022, using PubMed, EMbase, The Cochrane Library, China Biology Medicine (CBM), China National Knowledge Infrastructure (CNKI), WanFang Data, and VIP databases. After the independent screening of articles, data extraction, and quality assessment of included studies by two investigators, a meta-analysis was performed using Stata 16.0 software, and the prevalence was determined using a random-effects model. To identify potential sources of heterogeneity, subgroup analyses were conducted with subgroup categories including age, Body Mass Index (BMI), region, and survey year. Publication bias was assessed by visually examining the funnel plot and Egger\u2019s test.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Twenty studies were included in this meta-analysis. The results of the random-effects model indicated that the prevalence of OAB in Chinese women was 14% (95% Confidence Interval: 9%\u201318%). The prevalence increased significantly in the past decade (from 8% in pre-2006 to 18% in 2016\u20132021). A prevalence (18%) was observed among women aged 31\u201340 compared with other age groups. The BMI range of 24\u201327.9 (18%) was higher than the other groups. Additionally, the prevalence of this BMI range was comparatively higher in North China and Southwest China (21%) than in Central China and East China. In addition, publication bias was observed.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>OAB incidence has increased in Chinese women over the last two decades, affecting more than 20% of women aged 31\u201340 years and above. With the increasing prevalence of OAB, greater emphasis has been placed on implementing preventative and control measures.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0290396","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T18:57:21Z","timestamp":1703185041000},"page":"e0290396","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prevalence of overactive bladder in Chinese women: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"18","author":[{"given":"Shaoming","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengcheng","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dikai","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2159-8630","authenticated-orcid":true,"given":"Jiaguo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"issue":"1","key":"pone.0290396.ref001","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00192-009-0976-9","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.","volume":"21","author":"BT Haylen","year":"2010","journal-title":"Int Urogynecol J."},{"issue":"6","key":"pone.0290396.ref002","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"WF Stewart","year":"2003","journal-title":"World J Urol"},{"issue":"4","key":"pone.0290396.ref003","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.eururo.2005.04.026","article-title":"Prevalence of the overactive bladder syndrome by applying the International Continence Society definition.","volume":"48","author":"C Temml","year":"2005","journal-title":"Eur Urol."},{"issue":"5","key":"pone.0290396.ref004","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.urology.2010.08.039","article-title":"National community prevalence of overactive bladder in the United States stratified by sex and age","volume":"77","author":"KS Coyne","year":"2011","journal-title":"Urology"},{"issue":"3","key":"pone.0290396.ref005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/nau.22295","article-title":"The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial\/ethnic group and age: results from OAB-POLL.","volume":"32","author":"KS Coyne","year":"2013","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"pone.0290396.ref006","doi-asserted-by":"crossref","first-page":"19819","DOI":"10.1038\/s41598-020-76846-0","article-title":"Prevalence and bother of lower urinary tract symptoms and overactive bladder in Poland, an Eastern European Study.","volume":"10","author":"M Przydacz","year":"2020","journal-title":"Sci Rep."},{"issue":"8","key":"pone.0290396.ref007","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/nau.21072","article-title":"Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China.","volume":"30","author":"Y Wang","year":"2011","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"pone.0290396.ref008","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/nau.22429","article-title":"The prevalence and risk factors of OAB in middle-aged and old people in China.","volume":"33","author":"JG Wen","year":"2014","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"pone.0290396.ref009","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/luts.12193","article-title":"Prevalence of overactive bladder in China, Taiwan and South Korea: Results from a cross-sectional, population-based study.","volume":"11","author":"YC Chuang","year":"2019","journal-title":"Low Urin Tract Symptoms."},{"issue":"1 Pt 1","key":"pone.0290396.ref010","first-page":"170","article-title":"The prevalence and bother of lower urinary tract symptoms in men and women aged 40 years or over in Taiwan","volume":"118","author":"SP Liu","year":"2019","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"pone.0290396.ref011","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s12325-020-01588-4","article-title":"The Prevalence of Overactive Bladder Symptoms in Women in Algeria, Egypt, Jordan and Lebanon: A Cross-Sectional Population-Based Survey.","volume":"38","author":"G Al Edwan","year":"2021","journal-title":"Adv Ther."},{"issue":"18","key":"pone.0290396.ref012","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.2217\/cer-2022-0160","article-title":"Healthcare and economic burden of anticholinergic use in adults with overactive bladder: a systematic literature review.","volume":"11","author":"C Duperrouzel","year":"2022","journal-title":"J Comp Eff Res"},{"issue":"8","key":"pone.0290396.ref013","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s40265-018-0924-4","article-title":"Mirabegron: A Review in Overactive Bladder Syndrome","volume":"78","author":"ED Deeks","year":"2018","journal-title":"Drugs"},{"issue":"2","key":"pone.0290396.ref014","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.eururo.2018.10.006","article-title":"Vibegron (RVT-901\/MK-4618\/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder: A Multicenter, Phase IIb, Randomized, Double-blind, Controlled Trial.","volume":"75","author":"HD Mitcheson","year":"2019","journal-title":"Eur Urol"},{"issue":"1672","key":"pone.0290396.ref015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.58347\/tml.2023.1672a","article-title":"(2023) Drugs for overactive bladder","volume":"65","journal-title":"Med Lett Drugs Ther"},{"issue":"7","key":"pone.0290396.ref016","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/nau.22464","article-title":"Oestrogens and overactive bladder.","volume":"33","author":"D Robinson","year":"2014","journal-title":"Neurourol Urodyn"},{"issue":"9","key":"pone.0290396.ref017","first-page":"CD013519","article-title":"Acupuncture for treating overactive bladder in adults","volume":"9","author":"E Hargreaves","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"pone.0290396.ref018","first-page":"CD005493","article-title":"Botulinum toxin injections for adults with overactive bladder syndrome","author":"JB Duthie","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"pone.0290396.ref019","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrurol.2010.39","article-title":"Clinical trials: percutaneous tibial nerve stimulation for overactive bladder","volume":"7","author":"R Cartwright","year":"2010","journal-title":"Nat Rev Urol"},{"key":"pone.0290396.ref020","first-page":"1","article-title":"Celiac disease.","author":"A. Rostom","year":"2004","journal-title":"Evid Rep Technol Assess (Summ)"},{"key":"pone.0290396.ref021","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/0272989X05282643","article-title":"The interpretation of random-effects meta-analysis in decision models.","volume":"25","author":"AE Ades","year":"2005","journal-title":"Med Decis Making"},{"key":"pone.0290396.ref022","article-title":"Investigation and analysis of urination behavior and symptoms of overactive bladder among midwives.","author":"Y Hu","journal-title":"General Nursing."},{"key":"pone.0290396.ref023","author":"Y Wang","journal-title":"Epidemiological investigation of overactive bladder in women over 40 years old in Beijing and its impact on quality of life"},{"issue":"7","key":"pone.0290396.ref024","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/nau.20293","article-title":"Prevalence and risk factors of overactive bladder syndrome in Fuzhou Chinese women.","volume":"25","author":"W Zhang","year":"2006","journal-title":"Neurourol Urodyn."},{"issue":"3","key":"pone.0290396.ref025","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/nau.22290","article-title":"Association between occupational stress and risk of overactive bladder and other lower urinary tract symptoms: a cross-sectional study of female nurses in China.","volume":"32","author":"C Zhang","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"pone.0290396.ref026","author":"Y. Liu","year":"2013","journal-title":"Current status of lower urinary tract symptoms in female nurses and their relationship with urination behavior"},{"issue":"5","key":"pone.0290396.ref027","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s11255-015-0948-6","article-title":"Association between overactive bladder and peri-menopause syndrome: a cross-sectional study of female physicians in China.","volume":"47","author":"Y Chen","year":"2015","journal-title":"Int Urol Nephrol"},{"issue":"10","key":"pone.0290396.ref028","doi-asserted-by":"crossref","first-page":"e0139599","DOI":"10.1371\/journal.pone.0139599","article-title":"Association between Menopausal Symptoms and Overactive Bladder: A Cross-Sectional Questionnaire Survey in China.","volume":"10","author":"L Zhu","year":"2015","journal-title":"PLoS One."},{"issue":"20","key":"pone.0290396.ref029","first-page":"5","article-title":"Investigation and analysis of current situation and influencing factors of lower urinary tract symptoms in female nurses","volume":"30","author":"L Chen","year":"2015","journal-title":"Journal of Nursing Training"},{"issue":"9","key":"pone.0290396.ref030","first-page":"4","article-title":"Investigation and analysis of risk factors of overactive bladder in middle-aged and elderly people","volume":"30","author":"Y Liao","year":"2015","journal-title":"Journal of Clinical Urology"},{"issue":"1","key":"pone.0290396.ref031","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/nau.22659","article-title":"OAB epidemiological survey of general gynaecology outpatients and its effects on patient quality of life.","volume":"35","author":"F An","year":"2016","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"pone.0290396.ref032","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5213\/inj.1630464.232","article-title":"Prevalence of Spina Bifida Occulta and Its Relationship With Overactive Bladder in Middle-Aged and Elderly Chinese People.","volume":"20","author":"JW Wu","year":"2016","journal-title":"Int Neurourol J."},{"issue":"6","key":"pone.0290396.ref033","first-page":"3","article-title":"Investigation and analysis of cognition of lower urinary tract symptoms in gynecological outpatients","volume":"18","author":"NX Wu","year":"2017","journal-title":"Chinese Journal of Obstetrics and Gynecology"},{"key":"pone.0290396.ref034","author":"Z. Hu","year":"2018","journal-title":"Analysis of the current situation and influencing factors of OAB among female nurses in a tertiary hospital in Qiqihar city"},{"issue":"6","key":"pone.0290396.ref035","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/jan.13940","article-title":"Relationships among occupational stress, toileting behaviors, and overactive bladder in nurses: A multiple mediator model.","volume":"75","author":"D Xu","year":"2019","journal-title":"J Adv Nurs"},{"issue":"2","key":"pone.0290396.ref036","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/nau.24251","article-title":"Prevalence and risk factors of overactive bladder in Chinese children: A population-based study.","volume":"39","author":"D Xing","year":"2020","journal-title":"Neurourol Urodyn."},{"issue":"12","key":"pone.0290396.ref037","first-page":"5","article-title":"Prevalence status of overactive bladder in female college freshmen and its influence on psychology","volume":"41","author":"Y Liang","year":"2020","journal-title":"Chinese Journal of Urology"},{"issue":"16","key":"pone.0290396.ref038","first-page":"3","article-title":"Research on the status and influencing factors of overactive bladder among female nurses in operating room.","volume":"36","author":"H Wu","year":"2020","journal-title":"Modern Medicine."},{"key":"pone.0290396.ref039","doi-asserted-by":"crossref","first-page":"e1919325","DOI":"10.1001\/jamanetworkopen.2019.19325","article-title":"Limitations of Meta-analyses of Studies With High Heterogeneity","volume":"3","author":"PB Imrey","year":"2020","journal-title":"JAMA Netw Open"},{"key":"pone.0290396.ref040","first-page":"113","article-title":"Evaluation and management of overactive bladder: strategies for optimizing care.","volume":"8","author":"MG Willis-Gray","year":"2016","journal-title":"Res Rep Urol"},{"issue":"3","key":"pone.0290396.ref041","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000447205","article-title":"Overactive Bladder Syndrome: Evaluation and Management.","volume":"11","author":"E Leron","year":"2018","journal-title":"Curr Urol"},{"issue":"6","key":"pone.0290396.ref042","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1590\/s1677-5538.ibju.2021.99.12","article-title":"Current pharmacotherapy of overactive bladder","volume":"47","author":"EI Kreydin","year":"2021","journal-title":"Int Braz J Urol"},{"issue":"7","key":"pone.0290396.ref043","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/nau.20235","article-title":"The natural history of overactive bladder and stress urinary incontinence in older women in the community: a 3-year prospective cohort study.","volume":"25","author":"MM Donaldson","year":"2006","journal-title":"Neurourol Urodyn."},{"issue":"3","key":"pone.0290396.ref044","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/JU.0000000000000309","article-title":"Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA\/SUFU Guideline Amendment 2019.","volume":"202","author":"DJ Lightner","year":"2019","journal-title":"J Urol"},{"issue":"6","key":"pone.0290396.ref045","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","article-title":"A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment.","volume":"75","author":"B Peyronnet","year":"2019","journal-title":"Eur Urol."},{"issue":"2","key":"pone.0290396.ref046","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/00914150211001588","article-title":"Age Differences in Types and Perceptions of Daily Stress","volume":"94","author":"AR Stefaniak","year":"2022","journal-title":"Int J Aging Hum Dev"},{"key":"pone.0290396.ref047","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12894-015-0009-6","article-title":"Correlation between psychological stress levels and the severity of overactive bladder symptoms.","volume":"15","author":"H Lai","year":"2015","journal-title":"BMC Urol"},{"issue":"Suppl 4","key":"pone.0290396.ref048","first-page":"S7","article-title":"Pathophysiology of overactive bladder and urge urinary incontinence.","volume":"4 Suppl 4","author":"WD Steers","year":"2002","journal-title":"Rev Urol."},{"issue":"3","key":"pone.0290396.ref049","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrurol.2016.227","article-title":"Functional urological disorders: a sensitized defence response in the bladder-gut-brain axis.","volume":"14","author":"C Leue","year":"2017","journal-title":"Nat Rev Urol"},{"issue":"11","key":"pone.0290396.ref050","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11934-018-0839-3","article-title":"Recurrent Urinary Tract Infections in Females and the Overlap with Overactive Bladder","volume":"19","author":"F Nik-Ahd","year":"2018","journal-title":"Curr Urol Rep"},{"key":"pone.0290396.ref051","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejogrb.2016.03.024","article-title":"Is chronic urinary infection a cause of overactive bladder","volume":"201","author":"AA Balachandran","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"pone.0290396.ref052","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/tcmj.tcmj_38_20","article-title":"Recurrent urinary tract infection in women and overactive bladder\u2014Is there a relationship","volume":"33","author":"QS Ke","year":"2021","journal-title":"Tzu Chi Med J"},{"key":"pone.0290396.ref053","doi-asserted-by":"crossref","first-page":"752275","DOI":"10.3389\/fcimb.2021.752275","article-title":"Chronic Urinary Infection in Overactive Bladder Syndrome: A Prospective, Blinded Case Control Study.","volume":"11","author":"Z Khan","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"11 Suppl","key":"pone.0290396.ref054","first-page":"S580","article-title":"Overactive bladder significantly affects quality of life.","volume":"6","author":"P Abrams","year":"2000","journal-title":"Am J Manag Care."},{"issue":"5","key":"pone.0290396.ref055","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00192-010-1323-x","article-title":"The prevalence and risk factors of overactive bladder symptoms and its relation to pelvic organ prolapse symptoms in a general female population.","volume":"22","author":"TA de Boer","year":"2011","journal-title":"Int Urogynecol J"},{"issue":"2","key":"pone.0290396.ref056","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00192-012-1829-5","article-title":"Caffeine and urinary incontinence in US women.","volume":"24","author":"JL Gleason","year":"2013","journal-title":"Int Urogynecol J"},{"issue":"5","key":"pone.0290396.ref057","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0022-5347(17)38063-1","article-title":"Prevalence, incidence and correlates of urinary incontinence in healthy, middle-aged women","volume":"146","author":"KL Burgio","year":"1991","journal-title":"J Urol"},{"issue":"6","key":"pone.0290396.ref058","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF00184112","article-title":"Body mass index and adult female urinary incontinence","volume":"12","author":"S Mommsen","year":"1994","journal-title":"World J Urol"},{"issue":"5 Pt 1","key":"pone.0290396.ref059","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0029-7844(96)00013-0","article-title":"Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group.","volume":"87","author":"JS Brown","year":"1996","journal-title":"Obstet Gynecol."},{"issue":"2","key":"pone.0290396.ref060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/09513599909167542","article-title":"Urogenital symptoms in women aged 50\u201359 years. Women\u2019s Health in Lund Area (WHILSA) Study Group.","volume":"13","author":"G Samsioe","year":"1999","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"pone.0290396.ref061","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1159\/000052504","article-title":"Risk factors for urinary incontinence in both sexes. Analysis of a health screening project","volume":"39","author":"J Schmidbauer","year":"2001","journal-title":"Eur Urol."},{"issue":"3","key":"pone.0290396.ref062","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1471-0528.2003.02327.x","article-title":"Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study","volume":"110","author":"YS Hannestad","year":"2003","journal-title":"BJOG"},{"key":"pone.0290396.ref063","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/nau.23513","article-title":"The economic burden of overactive bladder (OAB) and its effects on the costs associated with other chronic, age-related comorbidities in the United States.","volume":"37","author":"E Durden","year":"2018","journal-title":"Neurourol Urodyn"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0290396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T18:58:03Z","timestamp":1703185083000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0290396"}},"subtitle":[],"editor":[{"given":"Sebastien","family":"Kenmoe","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":63,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0290396","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]}}}